$NOAL.V - As China's EV Sales Break Records, Investors Should Keep a Close Eye on NOA Lithium Brines Inc. (TSXV: NOAL) . 🔗 . TL;DR: As China's EV sales hit record highs with 1.11 million units in June 2025 (up 29.7% year-over-year), many investors are

#wallstwire $IINN - Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100 . Read: . RA'ANANA, Israel, July 10, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies.

#wallstwire $SLXN - Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines . Read: . Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further.

Gmail’s new ‘Manage subscriptions’ tool will help declutter your inbox.

#wallstwire $DRIO - Is DarioHealth the Hidden Gem of Digital Health? Recent Industry Trends Highlight Its Unique Position . Read: . TL;DR: As healthcare technology deals their focus gears 2025, DarioHealth (NASDAQ: DRIO) seems well positioned to benefit.

#wallstwire $PHGE - BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis . Read: . • Premier research journal article provides validation for BiomX’s phage.

#wallstwire $NVCT - Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies . Read: . Successful Completion of a Drug-Drug.

#wallstwire $NVCT - Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies . Read: . Successful Completion of a Drug-Drug.

Robinhood stock tokens face scrutiny in the European Union after OpenAI warning.

#wallstwire $IINN - Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework . Read: . RA'ANANA, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd.

#wallstwire $PYPD - Wall Street Analysts Think PolyPid, a $35M BioPharma Player, is Significantly Undervalued, Here’s Why . Read: . In the competitive landscape of biotechnology investments, discovering undervalued opportunities with significant upside.

Delta’s earnings and outlook seem cautious amid tariff uncertainties, while AZZ’s galvanizing deal might boost its long-term stance. Byrna’s growth story faces mixed signals ahead of earnings. Watch $DAL, $AZZ, $BYRN closely.

Carnival’s 11th straight earnings beat, fueled by record close-in bookings and strong onboard spending, might imply resilience in cruises despite economic and geopolitical headwinds. $CCL seems to be steering steady.

Progress Software ($PRGS) shows strong AI-driven growth with accelerating revenue and a key acquisition boosting its market. Earnings could further define its trajectory as July approaches—momentum seems to be building.

Scotts Miracle-Gro CEO says cannabis business is ‘mostly off the table’.

#wallstwire $IINN - Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase . Read: . RA'ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira.

#wallstwire $PYPD - 10X Radar: PolyPid : The Biotech That Broke My Rules . Read: . Biotech is the Tinder of investing. It always looks promising… until you actually go on the date. Dilution? Fair. No revenue? Definitely. Binary clinical readouts that.

X is piloting a program that lets AI chatbots generate Community Notes.

Fintech Bolt progresses its turnaround by landing Klarna as a partner.

Trump’s promise of the “best deal” on drug prices seems like a bold move, but the complexity of pharma pricing and politics might imply a long road ahead before real change hits patients or markets. #Healthcare.